We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 34

Further Guidance on German IT Security Act for Determination of Critical Infrastructures in the Health, Finance and Insurance as well as Transport and Traffic Sectors
  • Bird & Bird
  • Germany
  • July 12 2017

The IT-Security Act requires operators of critical infrastructure in certain industry sectors (energy, information technology and telecommunications


Federal Patent Court grants compulsory license
  • Bird & Bird
  • Germany
  • July 24 2017

The grant of a compulsory licence for the distribution of MSD’s HIV medicament "Isentress" (generic name raltegravir) by the German Federal Patent


The Bolar exemption protection of API suppliers
  • Bird & Bird
  • European Union, Germany
  • May 18 2014

The CJEU has recently been asked by the German courts to consider whether the Bolar exemption extends to a third party manufacturer which supplies a


New ECJ reference in relation to supplementary protection certificates for medicinal products
  • Bird & Bird
  • European Union, Germany, United Kingdom
  • December 20 2007

The latest reference to the ECJ under Council Regulation (EEC) No 179892 concerning the creation of a supplementary protection certificate for medicinal products, which establishes the scheme by which supplementary protection certificates (SPCs) enable de facto patent term extension of up to 5 years to be secured for pharmaceuticals, concerns the time limit for filing an application for such an SPC


Does requesting and receiving approval for a pharmaceutical create a threat of patent infringement? A German perspective
  • Bird & Bird
  • Germany
  • February 28 2008

Under German law, neither the application for a marketing approval nor obtaining it constitutes a ‘use’ act under Section 9 German Patent Act


ECJ: no pharmacy chains in Germany
  • Bird & Bird
  • European Union, Germany
  • July 17 2009

On 19 May 2009 the European Court of Justice (ECJ) has confirmed that Germany can have national legislation which prevents non-pharmacists from owning and operating pharmacies (joined cases C-17107 and C- 172-07


FSC decides on patentability of neural progenitor cells II (Brustle)
  • Bird & Bird
  • Germany
  • February 25 2013

Recently, the German Federal Supreme Court decided on a nullity action on the patentability of progenitor cells extracted from human embryonic stem


End of German Olanzapine battle: Federal Supreme Court upholds patent
  • Bird & Bird
  • Germany
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance


CJEU decides that binding retail price maintenance for prescription drugs in Germany violates EU law
  • Bird & Bird
  • European Union, Germany
  • October 19 2016

Upon a referral for preliminary ruling of the Higher Regional Court of Düsseldorf the CJEU Case C 14815 had to concern itself with the German law


Medical products: to be or not to be?
  • Bird & Bird
  • Germany
  • July 28 2010

The German Federal Court of Justice has given a key decision in its judgment of 14 January 2010 (Case I ZR 13807) relating to the differentiation of foodstuffs and medicinal products in borderline cases